First Ever Oral Medication For MS | MS Disability Claim Lawyer in Florida

What: New Drug for MS
Who: Nationa MS Society

In a release by the National Multiple Sclerosis Society, the first ever oral medication specifically for MS has been released. Fampridine-SR is for those who have difficulty walking when dealing with MS. It has been sent to the FDA for approval. A U.S. Food and Drug Administration advisory committee today recommended that the agency approve marketing of Fampridine-SR (Acorda Therapeutics, with a proposed name change to Amaya) for its ability to improve walking speed in people with any type of multiple sclerosis. While the FDA is not required to follow the recommendations of its advisory committees, it usually does. According to the sponsor, the agency is expected to make a final decision about whether to approve the drug for market on or before January 22, 2010.

This would fill a large gap in current MS treatments since there is no approved disease modifying therapies.